Results for this period
Third quarter1 April 2025 to 31 December 2025ConsolidatedJapanese GAAPThe width of the band at each stage is based on revenue. The narrower it becomes toward the bottom, the smaller the proportion of revenue that remains as profit. The dotted outline is the full-year forecast and the band inside it is the result for this period. The progress rate is the result divided by the forecast.
塗りつぶした部分が自己資本比率です。総資産のうち、返済のいらない自前の資金がどれだけかを表します。The thin vertical line indicates the level at the end of the previous fiscal year.
パチスロの保通協等による検定試験の適合率が低調に推移したことを主要因としてRS1の量産出荷が一時的に弱含みとなったこと、及びDi1の開発費300百万円を販管費に計上したこと。
No applicable matters.
| Item | Details |
|---|---|
| Fiscal Period Classification | Third quarter |
| Accounting standards | Japanese GAAP |
| Consolidated / non-consolidated | Consolidated |
| Period Covered | 1 April 2025 to 31 December 2025 |
| Net Sales | ¥1,657 million (YoY -24.9%) |
| Operating profit | ¥-399 million |
| Ordinary income | ¥-387 million |
| Profit attributable to owners of the parent | ¥-409 million |
| Net income per share | −¥130.05 |
| Equity ratio | End of the current fiscal period 86.3 / End of previous period 88.2 |
| Total assets | ¥3,709 million |
| Net assets | ¥3,202 million |
| Full-year earnings forecast | Net Sales ¥2,500 million (YoY -18.8%) / Operating profit ¥-275 million / Ordinary income ¥-260 million / Net income ¥-300 million |
| Annual Dividend Forecast | ¥0 → ¥0(0.0%) |
| Depreciation and amortization | ¥15,555 thousand |
| Breakdown of extraordinary income (loss) | Extraordinary income Not disclosed / Extraordinary loss Impairment loss on investment securities ¥19,979 thousand |
| Disclosure regarding the going concern assumption | No applicable matters. |
| Change in accounting policy | Changes due to revisions to standards No / Other changes No / Change in accounting estimate No / Restatement No |
| Changes in the scope of consolidation | New Number of companies 0 / Company name None / Excluded Number of companies 0 / Company name None |
| Availability of Supplementary Financial Results Materials | Yes |
| Availability of Financial Results Briefing | None (対象者:Not disclosed) |
| Issued Shares at Period-End | 3,152,400 shares |
| Treasury Shares at Period-End | 7,240株 |
| Factors Behind Changes in Business Performance | パチスロの保通協等による検定試験の適合率が低調に推移したことを主要因としてRS1の量産出荷が一時的に弱含みとなったこと、及びDi1の開発費300百万円を販管費に計上したこと。 |
Items this document does not state (14)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.パチスロの保通協等による検定試験の適合率が低調に推移したことを主要因として、RS1の量産出荷が一時的に弱含みとなった。また、次世代エッジAI半導体「Di1」の開発費300百万円を販管費に計上した。